Pediatrics · Pediatric Respiratory Disorders (Asthma, Bronchiolitis, Pneumonia)

A 6-month-old infant born at 28 weeks gestation with bronchopulmonary dysplasia is admitted with RSV-positive bronchiolitis. Which of the following is an indication for palivizumab prophylaxis in this child?

  • A Current RSV infection
  • B First episode of wheezing
  • C Family history of asthma
  • D Gestational age less than 32 weeks with chronic lung disease
Correct answer: D. Gestational age less than 32 weeks with chronic lung disease

Explanation

Palivizumab is indicated for RSV prophylaxis in premature infants with chronic lung disease of prematurity (bronchopulmonary dysplasia). It is given as monthly intramuscular injections during RSV season. It is not a treatment for active RSV infection. Family history of asthma and first wheezing episode are not indications.

Reference: Nelson Textbook of Pediatrics, 21st ed.

High-yield for: NEET PGINI-CETNExTFMGEUSMLEPLABMRCP

Written and medically reviewed by the StethoPrep medical team.

Sponsored

Want to test yourself?

Create a free account for timed mock tests, mistake tracking, and FSRS spaced-repetition revision across 43,000+ MCQs.

Start free → Log in

More Pediatric Respiratory Disorders (Asthma, Bronchiolitis, Pneumonia) MCQs

See all Pediatric Respiratory Disorders (Asthma, Bronchiolitis, Pneumonia) MCQs →